Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Guangdong Jianke Raises $130 Million for China Online Pharmacy

publication date: Sep 4, 2018

Guangdong Jianke Pharmaceutical raised $130 million in a funding round for its online pharmacy and medical advisory operations. The company, which claims to be  largest B2C pharmacy in China, has over 100 million customers, plus physical and internet hospitals. It is estimated to have a value of $500-$600 million and expects to IPO in the US sometime in 2019, after it completes one additional financing. The current round was led by GTJA, a Shenzhen healthcare investor. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital